The Effect of Ginger in treatment migraine
Phase 2
Completed
- Conditions
- Migraine.Nervous system disorder NOS
- Registration Number
- IRCT2014091411763N16
- Lead Sponsor
- Vice chancellor for research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion major criteria: Diagnose of migraine by neurologist based on the International Headache Society (IHS) criteria; Aged 17-60 years; At least one year history migraine; 2-10 migraine per month
exclusion major criteria: Patients with history of biliary disease or peptic ulcer; Allergy to ginger; Cardiovascular disease; Use of anticoagulant therapy; Secondary headaches due to head trauma; Use herbal medicines; Vitamin-mineral supplements; Pregnancy or Breastfeeding; Lack of cooperation in the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CRP levels. Timepoint: Baseline ,6 weeks after the intervention. Method of measurement: mg/dl by blood test.;Headache severity. Timepoint: Baseline ,6 weeks after the intervention. Method of measurement: Visual Analogue Scale.;Headache frequency. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: The frequency of migraine attacks per month by questionnaire.;Duration of headache. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: Based on minutes by questionnaire.;Frequency × Duration of headache. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: Calculation.
- Secondary Outcome Measures
Name Time Method